{"nctId":"NCT00286741","briefTitle":"Can Group Visits Improve Outcomes of Veterans With Diabetes","startDateStruct":{"date":"2006-06"},"conditions":["Diabetes","Hypertension"],"count":239,"armGroups":[{"label":"Medical group visits","type":"EXPERIMENTAL","interventionNames":["Other: Diabetes Group Management Visits"]},{"label":"Treatment as Usual control","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Diabetes Group Management Visits","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Primary care at one of two participating sites,\n* HbA1c \\>= 7.5%, Systolic BP \\> 140 OR Diastolic BP \\> 90 on 2 consecutive measurements\n\nExclusion Criteria:\n\n-Primary care provider excludes patient from study, -Patient states that primary care is shared with non-VA primary care provider, -New enrollment in endocrine clinic within the last 6 months, -Patient is reluctant to participate in group visit for any reason, -Reduced life expectancy, as determined by any of the following: -New York Heart Association Class IV congestive heart failure, -Lung disease requiring supplemental oxygen, -End-stage renal disease on dialysis, -Current malignancy with any evidence of disease or currently undergoing chemotherapy or radiation therapy, -Cirrhosis of the liver, or -AIDS (HIV disease does not exclude a patient in the absence of an AIDS diagnosis), -Five or more errors on Short Portable Mental Status Questionnaire, Psychotic illness with hospitalization within three years prior to enrollment","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Hemoglobin A1c","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.4","spread":"1.3"},{"groupId":"OG001","value":"8.7","spread":"1.5"}]}]}]},{"type":"PRIMARY","title":"Systolic Blood Pressure","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"140","spread":"14.8"},{"groupId":"OG001","value":"147","spread":"13.4"}]}]}]},{"type":"SECONDARY","title":"Cost-effectiveness, Proportion of Patients With LDL < 100, Health Services Utilization, Quality of Life (as Measured by DQoL), Patient Empowerment (as Measured by DES).","description":null,"paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":59,"n":133},"commonTop":["Hypoglycemia","Lightheadedness","Renal insufficiency","Hypotension","Hepatic insufficiency"]}}}